Web Desk:

Up till now, no vaccine and the specific drug have been discovered against the COVID-19, which continues to spread around the globe despite international lockdown and social distancing, World Health Organization (WHO) said.

“No pharmaceutical products have yet been shown to be safe and effective for the treatment of COVID-19,” the WHO cautioned. The organization, however, said that some medicines have been suggested as potential investigational therapies.

Many of these are now being studied or will soon have clinical trials, including the international Solidarity trial co-sponsored by the WHO and its partners. The global organization said that more than 90 countries are involved in the Solidarity trial to help find an effective treatment of the disease. “The Solidarity trial provides simplified procedures to enable even overloaded hospitals to participate with no paperwork required” as of April 8, according to the WHO. The WHO scientists stated that it will likely take at least one year to 18 months to develop a vaccine with the proper testing. Dr Mike Ryan, executive director of WHO’s emergency program, stressed that the trials are necessary and said in March that a “bad vaccine” could be as dangerous as a virus such as that of COVID-19.

“We will put together a mechanism, and we will appoint senior people from the north and the south that will work out the details of how they can accelerate production, but at the same time how they can ensure equitable distribution,” said WHO Director General Tedros Adhanom Ghebreyesus. News Agencies

Leave a Reply

Your email address will not be published. Required fields are marked *

About the Author

Quetta Voice is an English Daily covering all unfolding political, economic and social issues relating to Balochistan, Pakistan's largest province in terms of area. QV's main focus is on stories related to education, promotion of quality education and publishing reports about out of school children in the province. QV has also a vigilant eye on health, climate change and other key sectors.